ADMA vs GILD: Which Stock is Better?
Side-by-side comparison of Adma Biologics Inc and Gilead Sciences Inc in 2026
ADMA
Adma Biologics Inc
$15.39
GILD
Gilead Sciences Inc
$143.93
Key Metrics Comparison
| Metric | ADMA | GILD | Winner |
|---|---|---|---|
| Market Cap | $3.67B | $178.68B | GILD |
| P/E Ratio | 25.65 | 21.42 | GILD |
| EPS (TTM) | $0.60 | $6.72 | GILD |
| Revenue Growth | 0.2% | 0.0% | ADMA |
| Gross Margin | 57.4% | 78.8% | GILD |
Analyze ADMA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADMA or GILD a better investment?
Comparing ADMA and GILD: Adma Biologics Inc has a market cap of $3.67B while Gilead Sciences Inc has $178.68B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADMA and GILD?
ADMA (Adma Biologics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADMA or GILD?
Based on P/E ratios, GILD trades at a lower multiple (21.4x vs 25.6x).
Which is growing faster: ADMA or GILD?
ADMA has higher revenue growth at 0.2% vs 0.0% for GILD.
Which company is more profitable: ADMA or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 57.4% for ADMA.
Which is the larger company: ADMA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $178.68B compared to $3.67B for ADMA.
Should I buy ADMA or GILD in 2026?
Both ADMA and GILD have investment merit. ADMA trades at $15.39 while GILD trades at $143.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADMA and GILD stock?
Key differences: Market Cap ($3.67B vs $178.68B), P/E Ratio (25.6x vs 21.4x), Revenue Growth (0.2% vs 0.0%), Gross Margin (57.4% vs 78.8%).